A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 20,768 shares of IDYA stock, worth $576,727. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,768
Previous 20,768 -0.0%
Holding current value
$576,727
Previous $657,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$30.37 - $43.05 $131,168 - $185,932
4,319 Added 26.26%
20,768 $657,000
Q2 2024

Jul 29, 2024

SELL
$34.37 - $43.46 $60,697 - $76,750
-1,766 Reduced 9.7%
16,449 $577,000
Q1 2024

Apr 25, 2024

SELL
$34.2 - $47.13 $19,904 - $27,429
-582 Reduced 3.1%
18,215 $799,000
Q4 2023

Jan 30, 2024

BUY
$24.59 - $35.83 $11,950 - $17,413
486 Added 2.65%
18,797 $668,000
Q3 2023

Oct 25, 2023

SELL
$21.07 - $29.77 $28,528 - $40,308
-1,354 Reduced 6.89%
18,311 $494,000
Q2 2023

Aug 07, 2023

BUY
$13.33 - $25.53 $24,007 - $45,979
1,801 Added 10.08%
19,665 $462,000
Q1 2023

May 08, 2023

BUY
$13.49 - $18.72 $2,428 - $3,369
180 Added 1.02%
17,864 $245,000
Q4 2022

Feb 01, 2023

BUY
$14.47 - $18.17 $28,520 - $35,813
1,971 Added 12.54%
17,684 $321,000
Q3 2022

Nov 09, 2022

SELL
$9.24 - $15.79 $5,525 - $9,442
-598 Reduced 3.67%
15,713 $234,000
Q2 2022

Aug 09, 2022

SELL
$8.28 - $13.88 $6,425 - $10,770
-776 Reduced 4.54%
16,311 $225,000
Q1 2022

Apr 21, 2022

BUY
$11.18 - $24.02 $72,356 - $155,457
6,472 Added 60.97%
17,087 $191,000
Q4 2021

Feb 01, 2022

BUY
$20.95 - $26.88 $1,843 - $2,365
88 Added 0.84%
10,615 $251,000
Q3 2021

Nov 15, 2021

SELL
$17.26 - $27.08 $4,366 - $6,851
-253 Reduced 2.35%
10,527 $268,000
Q2 2021

Jul 30, 2021

BUY
$17.76 - $24.83 $11,455 - $16,015
645 Added 6.36%
10,780 $226,000
Q1 2021

May 03, 2021

BUY
$13.48 - $23.77 $136,619 - $240,908
10,135 New
10,135 $238,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.33B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.